₹ 1.0 Cr
Volume Transacted
(Dec 6, 2024)
1.9 K
Stocks Traded
(Dec 6, 2024)
Last Updated on: Dec 06, 2024
Alkem Laboratories Ltd
NSE: ALKEM
ISIN
INE540L01014
Last updated on: Dec 06, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Alkem Laboratories Ltd
NSE: ALKEM
Share Price
₹ 5534.85
-110.80 (-1.96%)
Last updated on: Dec 06, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
05 Dec 2024 | 5645.65 | 5697.45 | 5697.45 | 5588.3 |
04 Dec 2024 | 5668.4 | 5621.1 | 5715 | 5621.1 |
03 Dec 2024 | 5640.05 | 5713.5 | 5727 | 5625 |
02 Dec 2024 | 5692.15 | 5719.95 | 5750 | 5652.25 |
29 Nov 2024 | 5641.3 | 5493.15 | 5649.8 | 5490 |
28 Nov 2024 | 5458.05 | 5449.85 | 5489.95 | 5420 |
27 Nov 2024 | 5454 | 5500.05 | 5523.2 | 5401.05 |
26 Nov 2024 | 5479.6 | 5448.95 | 5528.85 | 5440 |
25 Nov 2024 | 5470.85 | 5702 | 5702 | 5378.2 |
22 Nov 2024 | 5571.95 | 5665 | 5665 | 5511.55 |
Date | Price (₹) |
---|---|
05 Dec 2024 | 5645.65 |
04 Dec 2024 | 5668.4 |
03 Dec 2024 | 5640.05 |
02 Dec 2024 | 5692.15 |
29 Nov 2024 | 5641.3 |
28 Nov 2024 | 5458.05 |
27 Nov 2024 | 5454 |
26 Nov 2024 | 5479.6 |
25 Nov 2024 | 5470.85 |
22 Nov 2024 | 5571.95 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 06 Dec 13:18 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Alkem Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Alkem Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Alkem Laboratories Ltd spurts 1.4%
Alkem Laboratories Ltd is up for a third straight session in a row. The stock is quoting a...
02 Dec 2024 13:05
Alkem Laboratories Ltd eases for fifth straight session
Alkem Laboratories Ltd fell for a fifth straight session today. The stock is quoting at Rs...
13 Nov 2024 13:14
Alkem Laboratories to conduct board meeting
Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 13 Nove...
07 Nov 2024 14:15
Alkem Laboratories inks licensing agreement with Sonnet
Alkem Laboratories has entered into a licensing agreement with US-based Sonnet BioTherapeu...
10 Oct 2024 18:35
Alkem Labs signs licensing agreement with Sonnet BioTherapeutics
SON-080 is Sonnet's proprietary version of 'atexakin alfa'. It has shown encouraging data ...
10 Oct 2024 14:53
Alkem Laboratories Ltd soars 2.24%
Alkem Laboratories Ltd is up for a third straight session in a row. The stock is quoting a...
04 Oct 2024 13:05
Unlimited trading starting at just Rs. 249*